top of page
logo_clearBKG_MNIndy (1).png

CVS to pay $37.8 million to settle claims over insulin pens

  • Reuters
  • Dec 2, 2025
  • 1 min read
The settlement resolves charges that CVS violated the federal False Claims Act between January 1, 2010 and December 31, 2020 by dispensing more insulin pens than doctors prescribed, obtaining reimbursements for premature refills, and underreporting how much insulin its pharmacies dispensed.







Comments

bottom of page